Brinker, Jeffrey - Johns Hopkins University

个人简介

Dr. Jeffrey Brinker directs the cardiac pacemaker service and is an expert in interventional cardiology including pacemakers and implantable cardio defibrillators (ICDs), angioplasty, heart catheterization and lead extraction. Dr. Brinker received his undergraduate degree from Hofstra University and his medical degree AOA summa cum laude from the State University of New York’s Downstate Medical Center. He interned at Johns Hopkins Hospital and entered the residency program at Kings County Hospital, interrupting his residency for military service. After completing his residency at Kings County, he pursued a fellowship in cardiology at the University of Louisville, Kentucky and in cardiovascular disease at the Johns Hopkins Hospital. Dr. Brinker joined the Johns Hopkins faculty in 1978. He directed the Catheterization Laboratory until 1990 and the Interventional Cardiology program until 1999. Dr. Brinker has published over 250 journal articles and book chapters on topics of interventional cardiology. His research interests include cardiovascular imaging, cardiac pacemakers and lead extraction. He has served on the editorial boards of several medical journals and is the recipient of numerous awards and honors, including seven military awards and Alpha Omega Alpha Honor Society. Dr. Brinker is a Fellow of the American College of Cardiology and serves on national health care committees and task forces. MD; Medicine, SUNY at Brooklyn College of Medicine (1970)

研究领域

Interventional cardiology; Cardiovascular imaging; Cardiac pacemakers; Lead extraction

近期论文

查看导师最新文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M, Brinker J, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. NEJM 331(8): 496-501, 1994. Miller JM, Rochitte CE, Dewey M, Arbab-Zadeh A, Niinuma H, Gottlieb I, Paul N, Clouse ME, Shapiro EP, Hoe J, Lardo AC, Bush DE, de Roos A, Cox C, Brinker J, Lima JA. Diagnostic performance of coronary angiography by 64-row CT. New England Journal of Medicine; 359 (22): 2324-36, Nov 27, 2008. Savage MP, Douglas JS Jr, Fischman DL, Pepine CJ, King SB 3rd, Werner JA, Bailey SR, Overlie PA, Fenton SH, Brinker JA, Leon MB, Goldberg S. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenous Vein DeNovo Trial Investigators. NEJM 337(11):740-747, 1997. Bittl, John A.; Strony, John; Brinker, Jeffrey A.; Ahmed, Waqar H.; Meckel, Clyde R.; Chairman, Bernard R., Maraganore, John; Deutsch, E.; Adelman, B., for the Hirulog Angioplasty Study Investigators. Treatment with Bivalirudin (Hirulog) as Compared with Heparin During Coronary Angioplasty for Unstable or Postinfarction Angina. The New England Journal of Medicine 333: 764-769, 1995. Reis SE, Gloth ST, Blumenthal RS, Resar JR, Zacur HA, Gerstenblith G, Brinker JA: Ethinyl Estradiol Acutely Attenuates Abnormal Coronary Vasomotor Responses to Acetylcholine in Postmenopausal Women. Circulation 89: 52-60, 1994. Grines CL, Watkins MW, Helmer G, Penny W, Brinker JA, et al. Angiogenic gene therapy (AGENT) trial in patients with stable angina pectoris. Circulation. 2002 Mar 19;105(11):1291-7. Heldman AW, Cheng L, Jenkins GM, Heller PF, Kim D-W, Ware M Jr., Nater C, Hruban RH, Rezai B, Abella BS, Bunge KE, Kinsella JL, Sollott SJ, Lakatta EG, Brinker JA, Hunter WL, Froehlich JP. Paclitaxel Stent Coating Inhibits Neointimal Hyperplasia at 4 Weeks in a Porcine Model of Coronary Restenosis. Circulation 103:2289; 2001.